Back
Also listed as
TCHBF
OTC
Day Range
$36.00
$38.38
52-Week Range
$36.00
$83.50
Volume
17
50D / 200D Avg
$36.00
/
$36.00
Prev Close
$36.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -21.6 | 0.4 |
| P/B | 2.0 | 2.9 |
| ROE % | -8.2 | 3.8 |
| Net Margin % | -12.5 | 3.9 |
| Rev Growth 5Y % | -2.9 | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Revenue declined -2.86% annually over 5 years
Earnings declined -256.18% over the past year
Debt/Equity of 0.19 — conservative balance sheet
Generating 102.67M in free cash flow
PEG of 0.07 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.93%
Growth
Revenue Growth (5Y)
-2.86%
Revenue (1Y)-9.79%
Earnings (1Y)-256.18%
FCF Growth (3Y)-9.60%
Quality
Return on Equity
-8.17%
ROIC2.21%
Net Margin-12.54%
Op. Margin4.78%
Safety
Debt / Equity
0.19
Current Ratio2.46
Interest Coverage4.29
Valuation
P/E Ratio
-21.63
P/B Ratio1.99
EV/EBITDA57.80
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -9.79% | Revenue Growth (3Y) | -11.43% |
| Earnings Growth (1Y) | -256.18% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 842.81M | Net Income (TTM) | -105.68M |
| ROE | -8.17% | ROA | -6.22% |
| Gross Margin | 35.22% | Operating Margin | 4.78% |
| Net Margin | -12.54% | Free Cash Flow (TTM) | 102.67M |
| ROIC | 2.21% | FCF Growth (3Y) | -9.60% |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 2.46 |
| Interest Coverage | 4.29 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | -21.63 | P/B Ratio | 1.99 |
| P/S Ratio | 2.71 | PEG Ratio | 0.07 |
| EV/EBITDA | 57.80 | Dividend Yield | 0.02% |
| Market Cap | 2.29B | Enterprise Value | 2.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 842.81M | 934.28M | 1.07B | 1.14B | 946.62M |
| Net Income | -105.68M | 67.66M | 132.08M | 121.13M | 121.66M |
| EPS (Diluted) | -1.67 | 1.05 | 2.06 | 1.89 | 1.98 |
| Gross Profit | 296.87M | 320.60M | 390.47M | 405.32M | 388.02M |
| Operating Income | 40.28M | 75.57M | 135.97M | 145.95M | 141.13M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.70B | 2.12B | 2.07B | 2.12B | 2.00B |
| Total Liabilities | 546.60M | 686.15M | 725.06M | 758.46M | 771.29M |
| Shareholders' Equity | 1.15B | 1.44B | 1.35B | 1.36B | 1.22B |
| Total Debt | 218.33M | 321.35M | 316.09M | 307.68M | 313.66M |
| Cash & Equivalents | 176.37M | 154.19M | 132.97M | 111.44M | 121.01M |
| Current Assets | 711.74M | 856.31M | 850.57M | 803.53M | 671.86M |
| Current Liabilities | 288.75M | 531.25M | 296.91M | 336.34M | 306.37M |